• Thu, May 19, 2016
  • Fri, May 20, 2016
  • Thu, May 26, 2016
  • Tue, May 24, 2016
  • Wed, May 25, 2016
  • Mon, May 23, 2016

Keay Nakae Initiated (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016

Keay Nakae of Chardan Capital, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍